About Us
Cereno Scientific is a clinical-stage biotech company developing disease-modifying therapies for rare cardiovascular and pulmonary diseases with high unmet medical need.
Science & Pipeline
Grounded in epigenetic modulation and strong clinical development, our pipeline targets the underlying biology of rare cardiopulmonary diseases.
Investors
Information supporting informed investment decisions, including financial reports, governance, and pipeline progress.
Newsroom
Company updates, press releases, and insights into our scientific and strategic progress.
LSX World Congress CEO Sten R. Sörensen will attend the LSX World Congress USA 2019 in Bostona.
